Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI®) for colorectal liver metastases does not predict tumour destruction or long-term outcome

European Journal of Surgical Oncology

Volumn 39, Issue 10, 2013, Pages 1122-1128

  Jones, R P ^a,b   Stattner S ^c   Dunne, D F J ^a,b   O'Grady, E ^b   Smethurst, A ^b   Terlizzo, M ^b   Malik, H Z ^b   Fenwick, S W ^b   Poston, G J ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

DEBIRI Colorectal Liver Metastases Surgery RECIST

Indexed keywords

DEBIRI; IRINOTECAN; NONIONIC CONTRAST MEDIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; FEMALE; HUMAN; LIVER FIBROSIS; LIVER RESECTION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TREATMENT RESPONSE; TUMOR NECROSIS;

COLORECTAL; DEBIRI; LIVER; METASTASES; RECIST; SURGERY;

ADULT; AGED; ANGIOGRAPHY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84884910289     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.07.087     Document Type: Article

References (19)

1. G. Folprecht, A. Grothey, S. Alberts, H.-R. Raab, and C.-H. Köhne Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 8 2005 Aug 1311 1319
2. L. Rubbia-Brandt, E. Giostra, and C. Brezault Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery Ann Oncol 18 2 2007 Feb 299 304
3. G.A. Poultsides, F. Bao, and E.L. Servais Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome Ann Surg Oncol 2012 Apr 4
4. M. Rees, P.P. Tekkis, F.K.S. Welsh, T. O'Rourke, and T.G. John Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 1 2008 Jan 125 135
5. R.C.G. Martin, J. Joshi, and K. Robbins Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study Ann Surg Oncol 18 1 2010 Aug 8 192 198
6. R.P. Jones J Clin Oncol 6 2012 Jun 30abstr 3613
7. H. Choi, C. Charnsangavej, and S.C. Faria Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria J Clin Oncol 25 13 2007 May 5 1753 1759
8. Y.S. Chun, J.-N. Vauthey, and P. Boonsirikamchai Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases JAMA 302 21 2009 Dec 12 2338 2344
9. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2 2009 Jan 228 247
10. D.G. Blazer, Y. Kishi, and D.M. Maru Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 33 2008 Nov 20 5344 5351
11. M.G. House, N.E. Kemeny, and M. Gönen Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer Ann Surg 254 6 2011 Dec 851 856
12. P.J. Allen, A. Nissan, and A.I. Picon Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases J Am Coll Surg 201 1 2005 Jul 57 65
13. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 3 1999 Sep 309 318 discussion 318-21
14. S. Benoist, A. Brouquet, and C. Penna Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24 24 2006 Aug 8 3939 3945
15. R.C.G. Martin, C.R. Scoggins, and K.M. McMasters Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience Ann Surg Oncol 2009 Aug 8
16. G. Fiorentini, C. Aliberti, and M. Tilli Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study Anticancer Res 32 4 2012 Apr 1387 1395
17. J.K.S. Ng, S.J. Urbanski, and N. Mangat Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study Cancer 112 2 2008 Jan 1 362 371
18. G. Folprecht, T. Gruenberger, and W.O. Bechstein Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 1 2010 Jan 38 47
19. C. Garufi, A. Torsello, and S. Tumolo Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial Br J Cancer 103 10 2010 Nov 11 1542 1547